Products Antibodies Polyclonal Antibodies Anti-GIPC1 Rabbit Polyclonal Antibody for WB, ELISA - O14908

Polyclonal Antibodies

Anti-GIPC1 Rabbit Polyclonal Antibody for WB, ELISA - O14908

Item Number : CM0014781

Price varies based on specs and customizations


Application
WB, ELISA
Cross Reactivity
Human, Mouse, Rat
Protein Weight
36kDa
ISO & CE icon

Shipping:

Contact us to get shipping details Enjoy On-time Dispatch Guarantee.

View Specs

Why Choose Us

Easy ordering process, quality products, and dedicated support for your business success.

Easy Process Quality Assured Dedicated Support

Core Product Specifications and Parameters

Parameter Value
Product Name GIPC1 Rabbit pAb
Remarks/Alias NIP; GIPC; IIP-1; OPDM2; TIP-2; SEMCAP; C19orf3; Hs.6454; GLUT1CBP; RGS19IP1; SYNECTIN; SYNECTIIN; GIPC1
Species Human
GeneID (Human) 10755
GeneID 10755
Immunogen Recombinant fusion protein containing a sequence corresponding to amino acids 1-333 of human GIPC1 (NP_005707.1)
Source Rabbit
Category Polyclonal Antibodies
Application WB, ELISA
Cross Reactivity Human, Mouse, Rat
SWISS O14908
Protein Weight 36kDa
Shipping Ice bag

Biological Background: GIPC1 Function and Localization

  • GIPC1 (PDZ domain-containing protein GIPC1) is also known as GAIP C-terminus-interacting protein, synectin, and RGS19-interacting protein 1, and contains a PDZ domain that mediates protein-protein interactions.
  • It may play a role in G protein-linked signaling pathways, interacting with regulators of G-protein signaling (RGS) proteins.
  • The protein is widely expressed in various tissues, as demonstrated by mRNA expression analysis, and is also detected at the protein level in skeletal muscle. Related references: PMID:9770488 PMID:32413282
  • GIPC1 localizes primarily to the cytoplasm and membrane, consistent with its role in membrane-associated signaling complexes.
  • Post-translational modifications include phosphorylation, and the gene undergoes alternative splicing, potentially generating multiple isoforms.
  • Mutations or dysregulation of GIPC1 have been associated with congenital muscular dystrophy and dystroglycanopathy, highlighting its importance in muscle function.

Experimental Guidance and Technical Tips

  • For Western blotting, the predicted molecular weight of GIPC1 is approximately 36 kDa; however, actual migration may vary depending on gel conditions and post-translational modifications—validate using positive control lysates from human, mouse, or rat tissues.
  • Given the immunogen is a full-length recombinant fusion protein (aa 1-333), the antibody may recognize multiple isoforms; confirm specificity in your experimental system.
  • For ELISA applications, titrate the antibody and optimize coating and blocking conditions for best signal-to-noise ratio.
  • Based on expression profiles, skeletal muscle lysates may serve as a suitable positive control for Western blot; consider validating in your own sample panel.

CamelBio: Your One-Stop Sourcing Bridge

CamelBio provides diagnostic manufacturers and research institutions with reliable sourcing of IVD raw materials. For G protein signaling research, we offer validated antibodies, recombinant proteins, and ancillary reagents. Our portfolio streamlines procurement for assay development and scale-up.

View more faqs for this product

REQUEST A QUOTE

Our professional team will reply to you within one business day. Please feel free to contact us!

Related Articles

From Molecular Binding to Manufacturing Discipline: How Reliable ELISA Kits Are Engineered

Explore the four operational mechanisms that govern ELISA kit performance, from passive coating and washing to signal generation and scalable IVD manufacturing.

Find out more

From Hapten to Reliable Result: Engineering Small-Molecule Immunoassays for Diagnostic Use

Discover how hapten chemistry, antibody selection, competitive formats, and validation determine small-molecule immunoassay performance.

Find out more

Why Similar Molecules Produce Different ELISA Sensitivity: The Engineering of PCP and PCA Assays

Explore how antibody affinity, hapten architecture, conjugate design, and sample extraction shape sensitivity in competitive PCP and PCA ELISAs.

Find out more

Multiplex Micro-Array Immunoassays: The Antibody Bottleneck Behind Faster, Smarter Diagnostics

Explore how multiplex micro-array immunoassays increase speed and data density, and why antibody specificity, conjugates, and consistency limit scale.

Find out more

Why Competitive Immunoassays Read Higher Than GC-MS—and How Raw Materials Close the Gap

Discover why competitive immunoassays overestimate target levels versus GC-MS, and how hapten, antibody, blocker, and buffer choices reduce bias.

Find out more

Why Dioxin Immunoassays Fail in Complex Matrices—and How to Engineer Them for Reliable Screening

Explore how matrix interference, antibody cross-reactivity, and sample preparation limit dioxin immunoassays—and how better materials and workflows improve accuracy.

Find out more